Treatment for de novo chronic myeloid leukemia in chronic phase
Hirase, C.; Matsumura, I.
Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 2): 298-303
2012
ISSN/ISBN: 0047-1852 PMID: 23133971 Document Number: 658883
Document emailed within 1 workday
Related Documents
Zuffa, E.; Bandini, G.; Bonini, A.; Santucci, M.A.; Martinelli, G.; Rosti, G.; Testoni, N.; Zaccaria, A.; Tura, S. 1998: Prior treatment with alpha-interferon does not adversely affect the outcome of allogeneic BMT in chronic phase chronic myeloid leukemia Haematologica 83(3): 231-236Cannistra, S.A.; Groshek, P.; Griffin, J.D. 1989: Granulocyte-macrophage colony-stimulating factor enhances the cytotoxic effects of cytosine arabinoside in acute myeloblastic leukemia and in the myeloid blast crisis phase of chronic myeloid leukemia Leukemia 3(5): 328-334
Takami, A.; Chuhjo, T.; Nakao, S. 2002: Relapse of chronic myeloid leukemia (CML) in lymphoid crisis after allogeneic bone marrow transplantation for CML in chronic phase with busulfan plus cyclophosphamide regimen Haematologica 87(6): 659-661
Cervantes, F.; Hernández-Boluda, J-Carlos.; Steegmann, J-Luis.; Conde, E.; Alvarez-Larrán, A.; López-Jiménez, J.; Osorio, S.; Villalón, Lía.; Camós, M.; García-Conde, J.; Odriozola, Jús. 2003: Imatinib mesylate therapy of chronic phase chronic myeloid leukemia resistant or intolerant to interferon: results and prognostic factors for response and progression-free survival in 150 patients Haematologica 88(10): 1117-1122
Meloni, G.; Russo, D.; Baccarani, M.; Testoni, N.; Martinelli, G.; Fanin, R.; Zuffa, E.; Rosti, G.; Alimena, G.; Saglio, G.; Mandelli, F.; Tura, S. 1999: A prospective study of alpha-interferon and autologous bone marrow transplantation in chronic myeloid leukemia. the Italian Co-operative Study Group on Chronic Myeloid Leukemia Haematologica 84(8): 707-715
Usman, M.; Syed, N.N.; Kakepoto, G.N.; Adil, S.N.; Khurshid, M. 2007: Chronic phase chronic myeloid leukemia: response of imatinib mesylate and significance of Sokal score, age and disease duration in predicting the hematological and cytogenetic response Journal of the Association of Physicians of India 55: 103-107
Sandberg, A.A.; Sonta, S. 1978: Chromosomal findings in relation to the blastic phase of chronic myeloid leukemia (CML) Bollettino dell'Istituto Sieroterapico Milanese 57(3): 334-343
Elovaara, E.; Kariniemi, A.L.; Somer, T. 1990: Sweet's syndrome associated with accelerated phase (blast crisis) of chronic myeloid leukemia Duodecim; Laaketieteellinen Aikakauskirja 106(8): 630-634
Enright, H.; Weisdorf, D.; Peterson, L.; Rydell, R.E.; Kaplan, M.E.; Arthur, D.C. 1992: Inversion of chromosome 16 and dysplastic eosinophils in accelerated phase of chronic myeloid leukemia Leukemia 6(5): 381-384
Guilhot, F. 1994: The role of interferon in the treatment of chronic myelogenous leukemia in chronic phase Nouvelle Revue Francaise d'Hematologie 36(Suppl 1): S39-S46
del Vecchio, T.; Carlesimo, F.; Cortese, M. 1976: Splenectomy in myeloid chronic leukemia in the pre-blastic phase. Presentation of 3 clinical cases and analysis of literature Annali Italiani di Chirurgia 48(1): 111-117
Frassoni, F.; Martinelli, G.; Saglio, G.; Sessarego, M.; Podestà, M.; Piaggio, G.; Farabegoli, P.; Zaccaria, A.; Testoni, N.; Remiddi, C. 1995: bcr/abl chimeric transcript in patients in remission after marrow transplantation for chronic myeloid leukemia: higher frequency of detection and slower clearance in patients grafted in advanced disease as compared to patients grafted in chronic phase Bone Marrow Transplantation 16(4): 595-601
Guilhot, F. 1993: Interferon alfa and low-dose cytosine-arabinoside for the treatment of patients with chronic myelogenous leukemia in chronic phase. French CML Study Group Seminars in Hematology 30(3 Suppl 3: 24-25
Tanzer, J.; Jacquillat, C.; Weil, M.; Briére, J.; Bussel, A.; Boiron, M.; Bernard, J. 1973: Treatment of chronic myeloid leukemia La Revue du Praticien 23(45): 3997-3998 Passim
O'Dwyer, M. 2003: Current use of imatinib in the treatment of chronic myeloid leukemia Haematologica 88(3): 241-244
Kawano, F.; Nishimura, Y.; Tsukamoto, A.; Satoh, M.; Sanada, I.; Shido, T. 1992: Successful treatment with low dose Ara-C in de novo acute myeloid leukemia with trilineage myelodysplasia International Journal of Hematology 55(1): 101-102
Preisler, H.D.; Raza, A.; Higby, D.; Kirshner, J.; Woll, J.; Bennett, J.; Winton, L.; Weiner, R.; Richman, C.; Golomb, H. 1984: Treatment of myeloid blastic crisis of chronic myelogenous leukemia Cancer Treatment Reports 68(11): 1351-1355
Deininger, M. 2014: The current status of ponatinib in the treatment of chronic myeloid leukemia Clinical Advances in Hematology and Oncology: H&o 12(5): 329-331
Faber, E.; Jarosová, M.; Divoký, V.; Luhový, M.; Komenda, S.; Sulovská, I.; Hubácek, J.; Slezák, P.; Papajik, T.; Raida, L.; Heczko, M.; Indrák, K. 1997: Interferon-alpha in the treatment of patients with chronic myeloid leukemia Vnitrni Lekarstvi 43(1): 13-17
Reiffers, J.; Montastruc, M.; Bilhou-Nabera, C. 1990: Chronic myeloid leukemia. Diagnosis, evolution and prognosis, treatment La Revue du Praticien 40(20): 1879-1885